Brinker Capital Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.99M | Sell |
17,059
-2,903
| -15% | -$954K | 0.04% | 364 |
|
|
2025
Q4 | $7M | Sell |
19,962
-1,333
| -6% | -$450K | 0.05% | 322 |
|
|
2025
Q3 | $6.88M | Buy |
21,295
+2,769
| +15% | +$861K | 0.05% | 320 |
|
|
2025
Q2 | $7.21M | Buy |
18,526
+107
| +0.6% | +$43K | 0.06% | 293 |
|
|
2025
Q1 | $8.01M | Sell |
18,419
-890,376
| -98% | -$357M | 0.08% | 247 |
|
|
2024
Q4 | $228M | Buy |
908,795
+895,658
| +6,818% | +$375M | 2.27% | 2 |
|
|
2024
Q3 | $6.83M | Buy |
13,137
+1,288
| +11% | +$688K | 0.07% | 275 |
|
|
2024
Q2 | $6.42M | Buy |
11,849
+614
| +5% | +$325K | 0.07% | 263 |
|
|
2024
Q1 | $5.83M | Buy |
11,235
+2,264
| +25% | +$1.13M | 0.06% | 295 |
|
|
2023
Q4 | $4.31M | Sell |
8,971
-110
| -1% | -$50.9K | 0.05% | 334 |
|
|
2023
Q3 | $3.95M | Sell |
9,081
-4,009
| -31% | -$1.82M | 0.05% | 355 |
|
|
2023
Q2 | $5.82M | Buy |
13,090
+4,842
| +59% | +$2.23M | 0.06% | 293 |
|
|
2023
Q1 | $3.79M | Buy |
8,248
+5,317
| +181% | +$2.53M | 0.05% | 340 |
|
|
2022
Q4 | $1.5M | Buy |
2,931
+176
| +6% | +$89.4K | 0.03% | 586 |
|
|
2022
Q3 | $1.25M | Buy |
2,755
+125
| +5% | +$59.8K | 0.03% | 619 |
|
|
2022
Q2 | $1.27M | Sell |
2,630
-99
| -4% | -$49K | 0.02% | 653 |
|
|
2022
Q1 | $1.34M | Buy |
2,729
+153
| +6% | +$69.9K | 0.02% | 688 |
|
|
2021
Q4 | $1.19M | Buy |
2,576
+922
| +56% | +$388K | 0.02% | 747 |
|
|
2021
Q3 | $625K | Sell |
1,654
-31
| -2% | -$11.8K | 0.01% | 912 |
|
|
2021
Q2 | $643K | Buy |
1,685
+300
| +22% | +$115K | 0.01% | 961 |
|
|
2021
Q1 | $497K | Sell |
1,385
-1,188
| -46% | -$382K | 0.01% | 910 |
|
|
2020
Q4 | $826K | Buy |
2,573
+803
| +45% | +$246K | 0.01% | 726 |
|
|
2020
Q3 | $475K | Buy |
+1,770
| New | +$476K | 0.01% | 920 |
|
|
2020
Q1 | – | Sell |
-79
| Closed | -$24K | – | 423 |
|
|
2019
Q4 | $24K | Buy |
79
+2
| +3% | +$550 | ﹤0.01% | 488 |
|
|
2019
Q3 | $18K | Buy |
77
+55
| +250% | +$15.1K | ﹤0.01% | 519 |
|
|
2019
Q2 | $6K | Hold |
22
| – | – | ﹤0.01% | 825 |
|
|
2019
Q1 | $6K | Hold |
22
| – | – | ﹤0.01% | 693 |
|
|
2018
Q4 | $6K | Sell |
22
-104
| -83% | -$28.6K | ﹤0.01% | 537 |
|
|
2018
Q3 | $35K | Buy |
126
+22
| +21% | +$5.71K | ﹤0.01% | 387 |
|
|
2018
Q2 | $25K | Hold |
104
| – | – | ﹤0.01% | 426 |
|
|
2018
Q1 | $23K | Buy |
+104
| New | +$24.4K | ﹤0.01% | 409 |
|
|
2017
Q4 | – | Sell |
-20
| Closed | -$4K | – | 532 |
|
|
2017
Q3 | $4K | Buy |
+20
| New | +$3.81K | ﹤0.01% | 498 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | – | – | 483 |
|
|
2015
Q4 | $0 | Buy |
+1
| New | +$138 | ﹤0.01% | 616 |
|
Other funds holding ELV
VCM
VPM
Brinker Capital Investments's ELV Position: Q1 2026 in Review
Brinker Capital Investments reduced its Elevance Health (ELV) stake by 15% in Q1 2026, selling an estimated $954K and leaving 17,059 shares worth $4.99M. The position accounts for 0.04% of the portfolio, ranked #364.
Brinker Capital Investments first reported a position in ELV in Q4 2015 and has held it in 33 quarters since. The position peaked at $228M in Q4 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Brinker Capital Investments held 17,059 shares of Elevance Health worth $4.99M as of Q1 2026.
- Brinker Capital Investments sold 2,903 Elevance Health shares in Q1 2026, an estimated $954K.
- Elevance Health made up 0.04% of Brinker Capital Investments's portfolio in Q1 2026, its #364 holding.
- Brinker Capital Investments first reported a position in Elevance Health in Q4 2015 and has held it in 33 quarters since.
- Brinker Capital Investments's Elevance Health position peaked at $228M in Q4 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.